Innovators wanting to market their products must first review the existing HA regulatory framework for medical devices to determine the correct pathway. The first step is to assess whether or not ...

ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today ...

Presents Shares and Growth Trends for Germany, France, United Kingdom, Italy, Spain, Russia, Poland, Bulgaria, Finland, and ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

Nightingale Health Plc Press release 7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulato ...

The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...

Centres of Excellence for Regulatory Science and Innovation (CERSIs) to help drive advancements in healthcare.Pioneering use of artificial intelligence (AI) could cut the time it takes to bring ...

UK MHRA asks for views on proposed guidance to support the safe regulation of new personalised cancer therapies: United Kingdom Tuesday, February 4, 2025, 11:00 Hrs [IST] The Medi ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...